Corxel US, Amanat Acquisition Agree to Business Combination
Corxel US and Amanat Acquisition Corp announced a definitive business combination agreement to create a publicly listed obesity-focused biopharmaceutical company.
Story updates
10:02:04 AM UTC
SquawkNews
AMANAT ACQUISITION CORP - INSTITUTIONAL INVESTORS COMMIT TO $300 MLN PIPE
10:04:10 AM UTC
SquawkNews
Amanat Acquisition Corp signed a definitive business combination with Corxel US, with an oversubscribed PIPE expected to bring total gross proceeds to approximately $300M plus ~$75M in trust, subject to reductions. Closing is expected in H1 2027, pending approvals.Material DetailsContext by AI Anal…
10:23:33 AM UTC
SquawkNews
Amanat Acquisition agreed to combine with Corxel Pharmaceuticals in a transaction that values Corxel's equity at an implied $200 million. Alongside the business combination agreement, Amanat entered into PIPE subscription agreements to sell shares or pre-funded warrants at closing, and its sponsor…